Gilead | WRAL TechWire


Gilead Sciences teams with TARGET PharmaSolutions on liver studies

Chapel Hill-based TARGET PharmaSolutions, a clinical data company focused on real-world evidence in disease studies, has formed a strategic partnership with Gilead Sciences to better understand two major liver disorders. Gilead is the sixth major pharmaceutical partner to join in TARGET-NASH, a study of nonalcoholic fatty liver disease, or nonalcoholic...

Read More